AWS Summit: A Peek at the ‘One FDA’ Plan to Modernize Tech Procurement
Acquisition leader Joseph Montgomery shares how AI and cloud technologies informed the agency’s new strategy.
The Food and Drug Administration recently released a new acquisition strategy that aims to transform how the agency buys technology to impact multiple mission areas. In an interview with FDA Office of Enterprise Portfolio Management Director Joseph Montgomery at AWS Summit, he highlights the importance of this strategy to create a “one FDA” ecosystem that prioritizes advanced technology and keeping pace with IT innovation.
Montgomery also highlights how he’s thinking about artificial intelligence, cybersecurity and cloud to impact financial operations (FinOps) and ultimately support FDA’s modernization goals.
Check out our full conference coverage.
This is a carousel with manually rotating slides. Use Next and Previous buttons to navigate or jump to a slide with the slide dots
-
JWCC Next Targets Longer-Term, More Flexible Cloud Approach
DISA emphasizes market research and partner feedback to adapt to changing technology landscape and demands.
3m read -
Driving Mission Impact with Scalable AI
IT leaders explore AI innovation, development and integration into cloud environments to drive operational excellence.
33m watch -
NCI's Tech-Based Therapy Helps Patients Battle HPV-Linked Respiratory Disease
A new tech-based therapy is helping NCI treat patients who suffer from a respiratory illness associated with HPV.
23m listen -
Opinion: America's Reindustrialization Must Be AI-Driven
The future of American industry built by artificial intelligence drives a need to upskill the workforce and leverage tariffs carefully.
4m read
